Work

Response to 'Dai W et al. Am J Cancer Res 2015;5(10):3270-3275' from the makers of nintedanib.

Year: 2016

Type: article

Abstract: We are writing as representatives of Boehringer Ingelheim (BI) to express our concern over an article recently published in the American Journal of Cancer Research.

Source: Europe PMC (PubMed Central)

Authors: Claudia-Nanette Gann, Nassim Morsli, Xiaoxiang Chen, José Barrueco

Institutions: Boehringer Ingelheim (Germany), Boehringer Ingelheim (France), Boehringer Ingelheim (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2534722702

FWCI:

Cites: 2

Cited by: 2

Related to: 10